Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
25-26 September, 2025
Not Confirmed
Not Confirmed
29 September-02 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
25-26 September, 2025
Industry Trade Show
Not Confirmed
29 September-02 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
08 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/phanes-therapeutics-announces-first-biliary-tract-carcinoma-btc-patient-dosed-in-clinical-study-of-spevatamig-in-combination-with-chemotherapy-302549488.html
27 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/phanes-therapeutics-announces-first-patient-dosed-in-clinical-study-of-mavrostobart-pt199-in-combination-with-chemotherapy-302464552.html
05 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/phanes-therapeutics-announces-first-patient-dosed-in-clinical-study-of-peluntamig-in-combination-with-atezolizumab-302446359.html
19 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/phanes-therapeutics-announces-first-patient-dosed-in-clinical-study-of-peluntamig-pt217-in-combination-with-chemotherapy-302380460.html
04 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/phanes-therapeutics-pt217-granted-fast-track-designation-by-the-fda-for-nepc-302322839.html
07 Nov 2024
// BUSINESSWIRE
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE